Vincamine
Systematic (IUPAC) name | |
---|---|
(3α,14β,16α)-14,15-dihydro- 14-hydroxyeburnamenine-14-carboxylic acid methyl ester OR methyl (15R,17S,19R)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2(7),3,5,8(18)-tetraene-17-carboxylate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 1617-90-9 |
ATC code | C04AX07 |
PubChem | CID 15376 |
IUPHAR/BPS | 349 |
ChemSpider | 14635 |
UNII | 996XVD0JHT |
KEGG | D08677 |
ChEMBL | CHEMBL1165342 |
Chemical data | |
Formula | C21H26N2O3 |
Molar mass | 354.44 g/mol |
| |
| |
(what is this?) (verify) |
Vincamine is a peripheral vasodilator that increases blood flow to the brain (sold under the trademark Oxybral SR) . Generic drugs containing vincamine exist in specific regions. Most common drug preparations are in the sustained release forms. Vincamine is a monoterpenoid indole alkaloid found in the leaves of Vinca minor, comprising about 25-65% of the indole alkaloids found in Vinca minor by weight. It can be synthesized from related alkaloids.[1]
Vincamine is often used as a nootropic agent to combat the effects of aging, or in conjunction with other nootropics (such as piracetam) for a variety of purposes.
See also
References
External links
- "Vincamine MSDS" (pdf).
- Chemical Selection Working Group. "Vincamine - 1617-90-9" (pdf). Summary of Data for Chemical Selection. NIH - United States National Institutes of Health.
|
This article is issued from Wikipedia - version of the Wednesday, October 22, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.